Kevin Schaefer,  —

Recent Posts

• Phase 2b trial plans for CS1 as PAH treatment endorsed by FDA
• FDA approves Yutrepia, inhaled treprostinil, for PAH and PH-ILD
• Ultrasound device for PH nets FDA breakthrough device designation
• How GLP-1 agonist medications changed one PHriend’s life
• Most PAH patients who’ve taken Uptravi for a decade are still alive